ストックスクリーナーアプリを入手
23.02
1.05%
-0.245
前日終値:
$23.27
開ける：
$23.16
24時間の取引高:
486.88K
Relative Volume:
0.68
時価総額：
$12.25B
収益：
$22.44B
当期純損益:
$1.35B
株価収益率:
12.12
EPS:
1.9002
ネットキャッシュフロー:
$2.03B
1週間 パフォーマンス:
-1.73%
1か月 パフォーマンス:
-6.97%
6か月 パフォーマンス:
-1.85%
1年 パフォーマンス:
-8.41%
1日の値動き範囲:
$22.91
$23.24
1週間の範囲:
$22.91
$23.66
52週間の値動き範囲:
$20.02
$27.64
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Compare FMS vs HCA, THC, EHC, DVA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
23.02 | 12.47B | 22.44B | 1.35B | 2.03B | 1.9002 |
HCA
Hca Healthcare Inc
|
418.59 | 87.96B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
266.62 | 21.95B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
121.43 | 11.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
181.78 | 11.18B | 13.84B | 1.10B | 1.49B | 10.42 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-20 | ダウングレード | Goldman | Buy → Neutral |
| 2025-10-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2025-09-02 | ダウングレード | UBS | Neutral → Sell |
| 2024-12-02 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-11-06 | 開始されました | Berenberg | Buy |
| 2024-01-08 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | アップグレード | HSBC Securities | Reduce → Hold |
| 2023-11-17 | アップグレード | Societe Generale | Hold → Buy |
| 2023-08-14 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-01 | 再開されました | Citigroup | Neutral |
| 2023-07-12 | 開始されました | Goldman | Buy |
| 2023-03-07 | 開始されました | Bernstein | Mkt Perform |
| 2023-01-03 | ダウングレード | Jefferies | Buy → Underperform |
| 2022-10-26 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-10-10 | ダウングレード | Jefferies | Buy → Hold |
| 2022-06-27 | アップグレード | Jefferies | Underperform → Buy |
| 2022-02-11 | ダウングレード | Jefferies | Hold → Underperform |
| 2021-11-23 | 開始されました | HSBC Securities | Hold |
| 2021-11-11 | アップグレード | Jefferies | Underperform → Hold |
| 2021-02-04 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-02-03 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2020-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2020-05-20 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | アップグレード | Jefferies | Hold → Buy |
| 2019-06-20 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-12-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | アップグレード | UBS | Neutral → Buy |
| 2018-08-28 | アップグレード | HSBC Securities | Hold → Buy |
| 2018-07-05 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | アップグレード | UBS | Sell → Neutral |
| 2017-12-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | アップグレード | Citigroup | Neutral → Buy |
| 2016-07-08 | アップグレード | Jefferies | Underperform → Hold |
| 2016-01-04 | アップグレード | JP Morgan | Neutral → Overweight |
| 2015-11-04 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | アップグレード | Goldman | Neutral → Buy |
| 2015-08-13 | ダウングレード | Societe Generale | Buy → Hold |
| 2015-07-31 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | 繰り返されました | Feltl & Co. | Hold |
| 2013-01-14 | アップグレード | HSBC Securities | Neutral → Overweight |
すべてを表示
Fresenius Medical Care Ag Adr (FMS) 最新ニュース
ETF Comparator - MacroMicro
Fresenius stock trades on solid footing as investors look beyond Fresenius Medical Care data - Ad-hoc-news.de
Fresenius Medical Care stock holds steady as mid-2026 trading data align with recent NYSE levels. - Ad-hoc-news.de
Fresenius Medical Care stock trades close to analyst fair value as investors weigh guidance and sect - Ad-hoc-news.de
FMS Posts Modest Gain: Fresenius Medical Care ADRs Hold Firm Above Key SupportTrade Entry Signals - vinanet.vn
Fresenius Medical Care (FMS) Edges Higher to $23.77, Holds Range Between Key Support and ResistanceAndrews Pitchfork - vinanet.vn
Fresenius Medical Care stock steadies around $23 as investors weigh recent buybacks and guidance - ad-hoc-news.de
Fresenius Medical Care stock holds steady near $24 as investors digest latest capital market update - ad-hoc-news.de
Fresenius Medical Care stock holds near $23 as investors weigh latest earnings - ad-hoc-news.de
Fresenius Medical Care AG (FMS) Stock Forecasts - Yahoo! Finance Canada
Weekly Recap: Q2 results & guidance reaffirmed and Cassie McLean named CEO - TradingView
Fresenius Medical Care (FMS) Advances to $24.10: Near-Term Support and Resistance in FocusMax Pain Level - vinanet.vn
Fresenius Medical Care Q2 2026 slides: margins soar despite volume pressure - Investing.com
Fresenius Medical Care plunges 9.6% as weak U.S. volumes overshadow Q2 beat - Investing.com
Earnings call transcript: Fresenius Medical Care beats Q2 2026 EPS, shares fall - Investing.com
Why is Fresenius Medical Care stock sliding today? - Investing.com
Fresenius Medical Care ADR earnings beat by $0.31, revenue was in line with estimates - Investing.com
Fresenius Medical Care's Margin Improvement Story Looks Merely Stalled, Not Over - Morningstar
Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery - Barchart.com
Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients - Fresenius Medical Care
Why is Fresenius Medical Care stock down today? - Investing.com
BNP Paribas Exane downgrades Fresenius Medical Care stock rating on dialysis volume concerns - Investing.com
Fresenius Medical Care launches analytics tool for kidney therapy By Investing.com - Investing.com South Africa
Fresenius Medical Care launches analytics tool for kidney therapy - Investing.com
Urology Devices Market Size to Reach USD 80.0 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy - Fresenius Medical Care
FMC stock steadies as Fresenius Medical Care keeps its U.S. listing - Ad-hoc-news.de
How home hemodialysis is redefining kidney care - Fresenius Medical Care
The 5008 CorDiax from Fresenius Medical Caredialyzers built for US clinics - ad-hoc-news.de
FMC Fresenius Medical Care, background on dialysis business and stock - Ad-hoc-news.de
ETFs Investing in Fresenius Medical Care AG Sponsored ADR Stocks - TradingView
FMEA Forecast — Price Target — Prediction for 2027 - TradingView
Fresenius Medical Care with a clear strategy focus, shares on NYSE and Xetra watch - ad-hoc-news.de
879529 Forecast — Price Target — Prediction for 2027 - TradingView
Fresenius Medical Care dips after US proposes lower dialysis reimbursement rate - Investing.com
Fresenius Medical Care with clear analyst view, shares tracked on Xetra and NYSE - AD HOC NEWS
Finding strength in change: George’s journey with dialysis - Fresenius Medical Care
Fresenius Medical Care Stock (DE0005785802): Shares trade near EUR 40.90 after a modest Xetra gain - AD HOC NEWS
Fresenius Medical Care Stock (DE0005785802): Quarterly earnings keep NYSE-listed shares in focus - AD HOC NEWS
Why Is Fresenius Medical Care Stock Trending Right Now - Kalkine Media
Fresenius Medical Care Stock (DE0005785802): Technical breakout to new 4-week high - AD HOC NEWS
Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model - Fresenius Medical Care
High-Volume Hemodiafiltration Remains the Benchmark for Survival Evidence in Dialysis - Fresenius Medical Care
Fresenius Medical Care stock (DE0005785802): dialysis specialist in focus after Q1 figures and new s - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): What investors are watching now - AD HOC NEWS
Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis - Fresenius Medical Care
The Ogden Water Project: Community Conservation - Fresenius Medical Care
Fresenius Medical Care launches €600M share buyback tranche By Investing.com - Investing.com India
Fresenius Medical Care launches €600M share buyback tranche - Investing.com
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million - Fresenius Medical Care
Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026 - Fresenius Medical Care
Fresenius Medical Care Ag Adr (FMS) 財務データ
収益
当期純利益
現金流量
EPS
1.41%
0.07%
大文字化:
|
ボリューム (24 時間):